The Monthly Monitor

Health Care Sector Insights

This timely update provides insights into health care sector stock performance and social impact themes related to U.N. Sustainable Development Goal 3 (Good Health and Well-Being).

Our Health Care Impact Themes

New or Innovative Treatments for Diseases Including Cancer
Access to Medicines and Health Care Services
New Solutions for Lowering Health Care Costs
Enhancing the Productivity of Medical Equipment, Services and Software

Monthly Highlights 

Health care stocks produced strong returns in December, capping a remarkable year that included the first recession and bear market in the U.S. in more than a decade and a market recovery to record highs.


Beyond the COVID Crisis

COVID-19 dominated the health care landscape in 2020, with nearly 86 million cases and two million deaths from the disease as of year-end.


Turning to Cancer Detection, Monitoring and Treatment 

According to the World Health Organization, more than 19 million people suffered from some form of cancer in 2020, with nearly 10 million dying from the disease. 


Company in Focus

Guardant Health is a leading precision oncology company, using its liquid biopsy technology, vast data sets and advanced analytics to help identify and monitor cancer. 



Download the Full Report

Investment return and principal value of security investments will fluctuate. The value at the time of redemption may be more or less than the original cost. Past performance is no guarantee of future results.

The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments' portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.

References to specific securities are for illustrative purposes only, and are not intended as recommendations to purchase or sell securities. Opinions and estimates offered constitute our judgment and, along with other portfolio data, are subject to change without notice.